This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
7. References
K. A. Al Barazanji, S. Wilson, J. Baker, D. S. Jessop, and M. S. Harbuz, Central Orexin-A Activates Hypothalamic-Pituitary-Adrenal Axis and Stimulates Hypothalamic Corticotropin Releasing Factor and Arginine Vasopressin Neurones in Conscious Rats, J. Neuroendocrinol. 13, 421ā424 (2001).
S. M. Antelman, H. Szechtman, P. Chin, and A. E. Fisher, Tail pinch-induced eating, gnawing and licking behavior in rats: dependence on the nigrostriatal dopamine system, Brain Res 99, 319ā337 (1975).
A. F. Arnsten, The biology of being frazzled, Science 280, 1711ā1712 (1998).
A. F. Arnsten, Development of the cerebral cortex: XIV. Stress impairs prefrontal cortical function, J. Am. Acad. Child Adolesc. Psychiatry 38, 220ā222 (1999).
A. F. Arnsten, Stress impairs prefrontal cortical function in rats and monkeys: role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms, Prog. Brain Res. 126, 183ā192 (2000).
A. F. Arnsten, C. Berridge, and D. S. Segal, Stress produces opioid-like effects on investigatory behavior, Pharmacol. Biochem. Behav. 22, 803ā809 (1985).
G. Aston-Jones and F. E. Bloom, Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle, J. Neurosci. 1, 876ā886 (1981).
M. Backberg, G. Hervieu, S. Wilson, and B. Meister, Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake, Eur. J. Neurosci. 15, 315ā328 (2002).
L. L. Bernardis and L. L. Bellinger, The lateral hypothalamic area revisited: ingestive behavior, Neurosci. Biobehav. Rev. 20, 189ā287 (1996).
C. W. Berridge and A. J. Dunn, Restraint-stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF, J. Neurosci. 9, 3513ā3521 (1989).
C. W. Berridge and R. A. EspaƱa, Synergistic sedative effects of noradrenergic Ī±1-and Ī²-receptor blockade on forebrain electroencephalographic and behavioral indices, Neuroscience 99, 495ā505 (2000).
C. W. Berridge and S. L. Foote, Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus, J. Neurosci. 11, 3135ā3145 (1991).
C. W. Berridge and S. L. Foote, Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain, J. Neurosci. 16, 6999ā7009 (1996).
C. W. Berridge, E. Mitton, W. Clark, and R. H. Roth, Engagement in a non-escape (displacement) behavior elicits a selective and lateralized suppression of frontal cortical dopaminergic utilization in stress, Synapse 32, 187ā197 (1999).
C. W. Berridge and J. OāNeill, Differential sensitivity to the wake-promoting actions of norepinephrine within the medial preoptic area and the substantia innominata, Behav. Neurosci. 115, 165ā174 (2001).
C. W. Berridge and B. D. Waterhouse, The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes, Brain Res. Brain Res. Rev. 42, 33ā84 (2003).
P. Bourgin, S. Huitron-Resendiz, A. D. Spier, V. Fabre, B. Morte, J. R. Criado, J. G. Sutcliffe, S. J. Henriksen, and L. de Lecea, Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons, J. Neurosci. 20, 7760ā7765 (2000).
G. Buzsaki, R. G. Bickford, G. Ponomareff, L. J. Thal, R. Mandel, and F. H. Gage, Nucleus basalis and thalamic control of neocortical activity in the freely moving rat, J. Neurosci. 8, 4007ā4026 (1988).
W. B. Cannon, The emergency function of the adrenal medulla in pain and the major emotions, Am. J. Physiol 33, 356ā372 (1914).
F. C. Chang and M. R. Opp, Corticotropin releasing hormone (CRF) as a regulator of waking, Neurosci. Biobehav. Rev. 25, 445ā453 (2001).
F. C. Chang and M. R. Opp, A corticotropin-releasing hormone antisense oligodeoxynucleotide reduces spontaneous waking in the rat, Regul. Pept. 117, 43ā52 (2004).
R. M. Chemelli, J. T. Willie, C. M. Sinton, J. K. Elmquist, T. Scammell, C. Lee, J. A. Richardson, S. C. Williams, Y. Xiong, Y. Kisanuki, T. E. Fitch, M. Nakazato, R. E. Hammer, C. B. Saper, and M. Yanagisawa, Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation, Cell 98, 437ā451 (1999).
C. T. Chen, L. L. Hwang, J. K. Chang, and N. J. Dun, Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats, Am. J. Physiol Regul. Integr. Comp Physiol 278, R692āR697 (2000).
J. E. Cluderay, D. C. Harrison, and G. J. Hervieu, Protein distribution of the orexin-2 receptor in the rat central nervous system, Regul. Pept. 104, 131ā144 (2002).
Y. Date, Y. Ueta, H. Yamashita, H. Yamaguchi, S. Matsukura, K. Kangawa, T. Sakurai, M. Yanagisawa, and M. Nakazato, Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems, Proc. Natl. Acad. Sci. 96, 748ā753 (1999).
M. G. Dube, S. P. Kalra, and P. S. Kalra, Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action, Brain Res 842, 473ā477 (1999).
A. J. Dunn, Stress-related activation of cerebral dopaminergic systems, Ann. N. Y. Acad. Sci. 537, 188ā205 (1988).
A. J. Dunn and C. W. Berridge, Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems, Pharmacol. Biochem. Behav. 27, 685ā691 (1987).
A. J. Dunn and C. W. Berridge, Is corticotropin-releasing factor a mediator of stress responses?, Ann. N. Y. Acad. Sci. 579, 183ā191 (1990).
A. J. Dunn and C. W. Berridge, Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?, Brain Res. Brain Res. Rev. 15, 71ā100(1990).
A. J. Dunn, C. W. Berridge, Y. I. Lai, and T. L. Yachabach, CRF-induced excessive grooming behavior in rats and mice, Peptides 8, 841ā844 (1987).
A. J. Dunn, A. L. Guild, N. R. Kramarcy, and M. D. Ware, Benzodiazepines decrease grooming in response to novelty but not ACTH or beta-endorphin, Pharmacol. Biochem. Behav. 15, 605ā608 (1981).
A. J. Dunn and R. W. Hurd, ACTH acts via an anterior ventral third ventricular site to elicit grooming behavior, Peptides 7, 651ā657 (1986).
J. K. Elmquist, C. F. Elias, and C. B. Saper, From lesions to leptin: hypothalamic control of food intake and body weight, Neuron 22, 221ā232 (1999).
R. A. EspaƱa, B. A. Baldo, A. E. Kelley, and C. W. Berridge, Wake-promoting and sleep-suppressing actions of hypocretin (orexin): Basal forebrain sites of action. Neuroscience 106, 699ā715 (2001).
R. A. EspaƱa, S. Plahn, and C. W. Berridge, Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin, Brain Res. 943, 224ā236 (2002).
R. A. EspaƱa, R. J. Valentino, and C. W. Berridge, Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration, Neuroscience 121, 201ā217 (2003).
J. Fadel and A. Y. Deutch, Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area, Neuroscience 111, 379ā387 (2002).
S. L. Foote, G. Aston-Jones, and F. E. Bloom, Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal, Proc. Natl. Acad. Sci. 77, 3033ā3037 (1980).
W. H. Gispen and R. L. Isaacson, ACTH-induced excessive grooming in the rat, Pharmacol. Ther. 12, 209ā246 (1981).
M. A. Greco and P. J. Shiromani, Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats, Brain Res Mol. Brain Res 88, 176ā182 (2001).
J. J. Hagan, R. A. Leslie, S. Patel, M. L. Evans, T. A. Wattam, S. Holmes, C. D. Benham, S. G. Taylor, C. Routledge, P. Hemmati, R. P. Munton, T. E. Ashmeade, A. S. Shah, J. P. Hatcher, P. D. Hatcher, D. N. Jones, M. I. Smith, D. C. Piper, A. J. Hunter, R. A. Porter, and N. Upton, Orexin A activates locus coeruleus cell firing and increases arousal in the rat, Proc. Natl. Acad. Sci. 96, 10911ā10916 (1999).
M. B. Hennessy and T. Foy, Nonedible material elicits chewing and reduces the plasma corticosterone response during novelty exposure in mice, Behav. Neurosci. 101, 237ā245 (1987).
G. J. Hervieu, J. E. Cluderay, D. C. Harrison, J. C. Roberts, and R. A. Leslie, Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord, Neuroscience 103, 777ā797 (2001).
J. A. Hobson, R. W. McCarley, and P. W. Wyzinski, Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups, Science 189, 55ā58 (1975).
W. E. Hoffman and M. I. Phillips, Regional study of cerebral ventricle sensitive sites to angiotensin II, Brain Res. 110, 313ā330 (1976).
T. L. Horvath, C. Peyron, S. Diano, A. Ivanov, G. Aston-Jones, T. S. Kilduff, and A. N. van Den Pol, Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system, J. Comp Neurol. 415, 145ā159 (1999).
T. Ida, K. Nakahara, T. Katayama, N. Murakami, and M. Nakazato, Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats, Brain Res. 821, 526ā529 (1999).
T. Ida, K. Nakahara, T. Murakami, R. Hanada, M. Nakazato, and N. Murakami, Possible involvement of orexin in the stress reaction in rats, Biochem. Biophys. Res. Commun. 270, 318ā323 (2000).
P. M. Iuvone and A. J. Dunn, Tyrosine hydroxylase activation in mesocortical 3,4-dihydroxyphenylethylamine neurons following footshock, J. Neurochem. 47, 837ā844 (1986).
A. Ivanov and G. Aston-Jones, Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons, Neuroreport 11, 1755ā1758 (2000).
M. JĆ”szberĆ©nyi, E. BujdosĆ³, I. Pataki, and G. Telegdy, Effects of orexins on the hypothalamic-pituitaryadrenal system, J. Neuroendocrinol. 12, 1174ā1178 (2000).
L. I. Kiyashchenko, B. Y. Mileykovskiy, Y. Y. Lai, and J. M. Siegel, Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area, J. Neurophysiol. 85, 2008ā2016 (2001).
G. F. Koob and F. E. Bloom, Corticotropin-releasing factor and behavior, Fed. Proc. 44, 259ā263 (1985).
G. F. Koob, K. Thatcher-Briton, A. Tazi, and M. Le Moal, Behavioral pharmacology of stress: Focus on CNS corticotropin-releasing factor, Adv. Exp. Med. Biol. 245, 25ā34 (1988).
T. M. Korotkova, O. A. Sergeeva, K. S. Eriksson, H. L. Haas, and R. E. Brown, Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins, J. Neurosci. 23, 7ā11 (2003).
V. M. Kumar, S. Datta, G. S. Chhina, and B. Singh, Alpha adrenergic system in medial preoptic area involved in sleep-wakefulness in rats, Brain Res. Bull. 16, 463ā468 (1986).
M. Kuru, Y. Ueta, R. Serino, M. Nakazato, Y. Yamamoto, I. Shibuya, and H. Yamashita, Centrally administered orexin/hypocretin activates HPA axis in rats, Neuroreport 11, 1977ā1980 (2000).
S. Levine, in: A definition of stress?/Animal stress, edited by G., Moberg (Waverly Press, Baltimore, 1985), pp. 51ā69.
R. E. Lewis and M. I. Phillips, Localization of the central pressor action of bradykinin to the cerebral third ventricle, Am. J. Physiol 247, R63āR68 (1984).
L. Lin, J. Faraco, R. Li, H. Kadotani, W. Rogers, X. Lin, X. Qiu, P. J. de Jong, S. Nishino, and E. Mignot, The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene, Cell 98, 365ā376 (1999).
M. Lubkin and A. Stricker-Krongrad, Independent feeding and metabolic actions of orexins in mice 714, Biochem. Biophys. Res. Commun. 253, 241ā245 (1998).
L. K. Malendowicz, C. Tortorella, and G. G. Nussdorfer, Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade, J. teroid Biochem. Mol. Biol. 70, 185ā188 (1999).
B. N. Mallick and M. N. Alam, Different types of norepinephrinergic receptors are involved in preoptic area mediated independent modulation of sleep-wakefulness and body temperature, Brain Res 591, 8ā19 (1992).
J. N. Marcus, C. J. Aschkenasi, C. E. Lee, R. M. Chemelli, C. B. Saper, M. Yanagisawa, and J. K. Elmquist, Differential expression of orexin receptors 1 and 2 in the rat brain, J. Comp Neurol. 435, 6ā25 (2001).
M. Marinelli and P. V. Piazza, Interaction between glucocorticoid hormones, stress and psychostimulant drugs, Eur. J. Neurosci. 16, 387ā394 (2002).
P. J. Martins, V. DāAlmeida, M. Pedrazzoli, L. Lin, E. Mignot, and S. Tufik, Increased hypocretin-1 (orexina) levels in cerebrospinal fluid of rats after short-term forced activity, Regul. Pept. 117, 155ā158 (2004).
J. W. Mason, The scope of psychoendocrine research, Psychosom Med 565ā575 (1968).
G. Mazzocchi, L. K. Malendowicz, L. Gottardo, F. Aragona, and G. G. Nussdorfer, Orexin A Stimulates Cortisol Secretion from Human Adrenocortical Cells through Activation of the Adenylate Cyclase-Dependent Signaling Cascade, J. Clin. Endocrinol. Metab 86, 778ā782 (2001).
I. Merchenthaler, Corticotropin Releasing-Factor (Crf)-Like Immunoreactivity in the Rat Central Nervous-System-Extrahypothalamic Distribution, Peptides 5, 53ā69 (1984).
R. Metherate, C. L. Cox, and J. H. Ashe, Cellular bases of neocortical activation: modulation of neural oscillations by the nucleus basalis and endogenous acetylcholine, J. Neurosci. 12, 4701ā4711 (1992).
T. Nambu, T. Sakurai, K. Mizukami, Y. Hosoya, M. Yanagisawa, and K. Goto, Distribution of orexin neurons in the adult rat brain, Brain Res. 827, 243ā260 (1999).
L. K. Nisenbaum, M. J. Zigmond, A. F. Sved, and E. D. Abercrombie, Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor, J. Neurosci. 11, 1478ā1484 (1991).
S. Nishino, B. Ripley, S. Overeem, G. J. Lammers, and E. Mignot, Hypocretin (orexin) deficiency in human narcolepsy, Lancet 355, 39ā40 (2000).
K. W. Nowak, P. Mackowiak, M. M. Switonska, M. Fabis, and L. K. Malendowicz, Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies, Life Sci. 66, 449ā454 (2000).
M. E. Page, C. W. Berridge, S. L. Foote, and R. J. Valentino, Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress, Neurosci. Lett. 164, 81ā84 (1993).
C. Peyron, D. K. Tighe, A. N. van Den Pol, L. de Lecea, H. C. Heller, J. G. Sutcliffe, and T. S. Kilduff, Neurons containing hypocretin (orexin) project to multiple neuronal systems, J. Neurosci. 18, 9996ā10015 (1998).
D. C. Piper, N. Upton, M. I. Smith, and A. J. Hunter, The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats, Eur. J. Neurosci. 12, 726ā730 (2000).
T. W. Robbins, Cortical noradrenaline, attention and arousal, Psychol. Med. 14, 13ā21 (1984).
F. Sakamoto, S. Yamada, and Y. Ueta, Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons, Regul. Pept. 118, 183ā191 (2004).
T. Sakurai, A. Amemiya, M. Ishii, I. Matsuzaki, R. M. Chemelli, H. Tanaka, S. C. Williams, J. A. Richarson, G. P. Kozlowski, S. Wilson, J. R. Arch, R. E. Buckingham, A. C. Haynes, S. A. Carr, R. S. Annan, D. E. McNulty, W. S. Liu, J. A. Terrett, N. A. Elshourbagy, D. J. Bergsma, and M. Yanagisawa, Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior, Cell 92, 1 (1998).
T. Sakurai, T. Moriguchi, K. Furuya, N. Kajiwara, T. Nakamura, M. Yanagisawa, and K. Goto, Structure and function of human prepro-orexin gene, J. Biol. Chem. 274, 17771ā17776 (1999).
W. K. Samson, B. Gosnell, J. K. Chang, Z. T. Resch, and T. C. Murphy, Cardiovascular regulatory actions of the hypocretins in brain, Brain Res 831, 248ā253 (1999).
W. K. Samson, M. M. Taylor, M. Follwell, and A. V. Ferguson, Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates, Regul. Pept. 104, 97ā103 (2002).
P. E. Sawchenko and L. W. Swanson, Localization, Colocalization, and Plasticity of Corticotropin-Releasing Factor Immunoreactivity in Rat-Brain, Federation Proceedings 44, 221ā227 (1985).
H. Selye, The general adaptation syndrome and the diseases of adaptation, J. Clin. Endocrinol. Metab 6, 117ā230 (1946).
T. Shirasaka, S. Miyahara, T. Kunitake, Q. H. Jin, K. Kato, M. Takasaki, and H. Kannan, Orexin depolarizes rat hypothalamic paraventricular nucleus neurons, Am. J. Physiol Regul. Integr. Comp Physiol 281, R1114āR1118 (2001).
T. Shirasaka, M. Nakazato, S. Matsukura, M. Takasaki, and H. Kannan, Sympathetic and cardiovascular actions of orexins in conscious rats, Am. J. Physiol 277, R1780āR1785 (1999).
E. A. Stone, Effect of stress on norepinephrine-stimulated cyclic AMP formation in brain slices, Pharmacol. Biochem. Behav. 8, 583ā591 (1978).
E. A. Stone and J. E. Platt, Brain adrenergic receptors and resistance to stress, Brain Res. 237, 405ā414 (1982).
R. Suzuki, H. Shimojima, H. Funahashi, S. Nakajo, S. Yamada, J. L. Guan, S. Tsurugano, K. Uehara, Y. Takeyama, S. Kikuyama, and S. Shioda, Orexin-1 receptor immunoreactivity in chemically identified target neurons in the rat hypothalamus, Neurosci. Lett. 324, 5ā8 (2002).
D. C. Sweet, A. S. Levine, C. J. Billington, and C. M. Kotz, Feeding response to central orexins, Brain Res 821, 535ā538 (1999).
S. Taheri, M. Mahmoodi, J. Opacka-Juffry, M. A. Ghatei, and S. R. Bloom, Distribution and quantification of immunoreactive orexin A in rat tissues, FEBS Lett. 457, 157ā161 (1999).
T. C. Thannickal, R. Y. Moore, R. Nienhuis, L. Ramanathan, S. Gulyani, M. Aldrich, M. Cornford, and J. M. Siegel, Reduced number of hypocretin neurons in human narcolepsy, Neuron 27, 469ā474 (2000).
A. M. Thierry, J. P. Tassin, G. Blanc, and J. Glowinski, Selective activation of mesocortical DA system by stress, Nature 263, 242ā244 (1976).
A. Tsuda, M. Tanaka, Y. Ida, I. Shirao, Y. Gondoh, M. Oguchi, and M. Yoshida, Expression of aggression attenuates stress-induced increases in rat brain noradrenaline turnover, Brain Res 474, 174ā180 (1988).
W. Vale, J. Spiess, C. Rivier, and J. Rivier, Characterization of A 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and Beta-Endorphin, Science 213, 1394ā1397 (1981).
R. J. Valentino, S. L. Foote, and G. Aston-Jones, Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus, Brain Res. 270, 363ā367 (1983).
N. M. Vittoz and C. W. Berridge, Hypocretin increases dopamine efflux in rat prefrontal cortex and not in nucleus accumbens, Society for Neuroscience Meeting November 8ā12 (New Orleans, LA), abstract 931.14, (2003).
Y. Yoshida, N. Fujiki, T. Nakajima, B. Ripley, H. Matsumura, H. Yoneda, E. Mignot, and S. Nishino, Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities, Eur. J. Neurosci. 14, 1075ā1081 (2001).
G. Yoshimichi, H. Yoshimatsu, T. Masaki, and T. Sakata, Orexin-A regulates body temperature in coordination with arousal status, Exp. Biol. Med. 226, 468ā476 (2001).
J. M. Zeitzer, C. L. Buckmaster, K. J. Parker, C. M. Hauck, D. M. Lyons, and E. Mignot, Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness, J. Neurosci. 23, 3555ā3560 (2003).
L. Zhu, T. Onaka, T. Sakurai, and T. Yada, Activation of orexin neurones after noxious but not conditioned fear stimuli in rats, Neuroreport 13, 1351ā1353 (2002).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Berridge, C.W., EspaƱa, R.A. (2005). Hypocretin/Orexin in Stress and Arousal. In: de Lecea, L., Sutcliffe, J.G. (eds) Hypocretins. Springer, Boston, MA. https://doi.org/10.1007/0-387-25446-3_24
Download citation
DOI: https://doi.org/10.1007/0-387-25446-3_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25000-7
Online ISBN: 978-0-387-25446-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)